Autoimmunity in dengue pathogenesis (Q33405382)

26 July 2017

1 reference

title

Autoimmunity in dengue pathogenesis (English)

1 reference

modulation by virus of host process

26 July 2017

1 reference

0 references

0 references

Trai-Ming Yeh

3

0 references

Yee-Shin Lin

10

object named as

Yee-Shin Lin

1 reference

26 July 2017

2

Chiou-Feng Lin

1 reference

26 July 2017

1

Shu-Wen Wan

1 reference

26 July 2017

5

Hsiao-Sheng Liu

1 reference

26 July 2017

Ching-Chuan Liu

4

1 reference

26 July 2017

Shuying Wang

6

1 reference

26 July 2017

Pin Ling

7

1 reference

26 July 2017

Robert Anderson

8

1 reference

26 July 2017

Huan-Yao Lei

9

1 reference

26 July 2017

12 December 2012

1 reference

Journal of the Formosan Medical Association

26 July 2017

1 reference

26 July 2017

112

1 reference

26 July 2017

1

1 reference

26 July 2017

3-11

1 reference

Dengue: a continuing global threat

26 July 2017

2 references

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NRMICRO2460

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue virus selectively induces human mast cell chemokine production

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Antibody Responses Are Generated to Immunodominant ELK/KLE-Type Motifs on the Nonstructural-1 Glycoprotein during Live Dengue Virus Infections in Mice and Humans: Implications for Diagnosis, Pathogenesis, and Vaccine Design

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue: the risk to developed and developing countries

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Autoimmune pathogenesis in dengue virus infection

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue and dengue hemorrhagic fever

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Neutralization and antibody-dependent enhancement of dengue viruses

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Development of Cross-Reactive Antibodies to Plasminogen during the Immune Response to Dengue Virus Infection

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

How innate immune mechanisms contribute to antibody-enhanced viral infections

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Generation of IgM anti-platelet autoantibody in dengue patients

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Characteristics of dengue epidemics in Taiwan

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Autoimmune features caused by dengue fever: a case report

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Hepatic damage associated with dengue-2 virus replication in liver cells of BALB/c mice

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue-infected patients: relationship between virus detection and pre-existing specific antibodies

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue fever evolving into systemic lupus erythematosus and lupus nephritis: a case report

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Antibodies against dengue virus E protein peptide bind to human plasminogen and inhibit plasmin activity

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Molecular mimicry between virus and host and its implications for dengue disease pathogenesis

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Elevated levels of IL-8 in dengue hemorrhagic fever

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral Loads

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Enhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage Development

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Patient and Mouse Antibodies against Dengue Virus Nonstructural Protein 1 Cross-React with Platelets and Cause Their Dysfunction or Depletion

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

C-Terminal Region of Dengue Virus Nonstructural Protein 1 Is Involved in Endothelial Cell Cross-Reactivity via Molecular Mimicry

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Activation of coagulation and fibrinolysis during dengue virus infection.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue virus pathogenesis: an integrated view

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue virus structural differences that correlate with pathogenesis.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

The pathogenesis of dengue

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Update on the global spread of dengue

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Critical issues in dengue vaccine development

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Human skin Langerhans cells are targets of dengue virus infection

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced Hemorrhage

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue virus life cycle: viral and host factors modulating infectivity

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Immune response to dengue virus and prospects for a vaccine

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Dengue virus infection of mast cells triggers endothelial cell activation.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Antibodies from dengue patient sera cross-react with endothelial cells and induce damage

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Immunopathogenesis of dengue virus infection

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Antibody-enhanced binding of dengue-2 virus to human platelets.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Characteristic of dengue disease in Taiwan: 2002-2007.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

Crosstalk between coagulation and inflammation during Dengue virus infection

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JFMA.2012.11.006

10.1016/J.JFMA.2012.11.006

2 November 2022

Identifiers

DOI

1 reference

26 July 2017

1 reference